O6-Methylguanine-Methyltransferase (MGMT) Promoter Methylation Status in Glioma Stem-Like Cells is Correlated to Temozolomide Sensitivity Under Differentiation-Promoting Conditions

Glioblastoma (GBM) is the most malignant type of primary brain tumor with a very poor prognosis. The actual standard protocol of treatment for GBM patients consists of radiotherapy and concomitant temozolomide (TMZ). However, the therapeutic efficacy of this treatment is limited due to tumor recurre...

Descripción completa

Detalles Bibliográficos
Autores principales: Villalva, Claire, Cortes, Ulrich, Wager, Michel, Tourani, Jean-Marc, Rivet, Pierre, Marquant, Celine, Martin, Sebastien, Turhan, Ali G., Karayan-Tapon, Lucie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Molecular Diversity Preservation International (MDPI) 2012
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3397507/
https://www.ncbi.nlm.nih.gov/pubmed/22837675
http://dx.doi.org/10.3390/ijms13066983

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3397507/
https://www.ncbi.nlm.nih.gov/pubmed/22837675
http://dx.doi.org/10.3390/ijms13066983

Ejemplares similares